Syndecan-1 (CD138) Expression in Acute Myeloblastic Leukemia Cells

Author： Seftalioglu Aysel   Seftalioglu Aysel   Seftalioglu Aysel   Seftalioglu Aysel   Seftalioglu Aysel   Seftalioglu Aysel   Seftalioglu Aysel   Seftalioglu Aysel   Seftalioglu Aysel   Seftalioglu Aysel  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.42, Iss.1, 2003-01, pp. : 71-74

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Brucellosis: a rare cause of febrile neutropenia in acute myeloblastic leukemia

By Ozbalci Demircan  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 255-257

Humana Press, Inc

Access to resources Recommend Favorite

A Potent Anti-Carcinoma and Anti-Acute Myeloblastic Leukemia Agent, AG490

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 7, 2008-10 ,pp. : 717-722

Bentham Science Publishers

Access to resources Recommend Favorite

CD19 expression in acute leukemia is not restricted to the cytogenetically aberrant populations

By Francis Jawad  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1517-1520

Informa Healthcare

Access to resources Recommend Favorite

Hypoxia reduces CD138 expression and induces an immature and stem cell-like transcriptional program in myeloma cells

By              

International Journal of Oncology, Vol. 43, Iss. 6, 2013-01 ,pp. : 1809-1816

Spandidos Publications

Access to resources Recommend Favorite

CD1d levels in peripheral blood of patients with acute myeloid leukemia and acute lymphoblastic leukemia

By                  

Oncology Letters, Vol. 8, Iss. 2, 2014-01 ,pp. : 825-830

Spandidos Publications

Access to resources Recommend Favorite